Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Invion ( (AU:IVX) ).
Invion Limited has requested and been granted a trading halt on its ordinary shares on the ASX as it prepares to announce a capital raising. The halt, in place until 2 February 2026 or until the capital-raising announcement is released, is intended to help the company manage its continuous disclosure obligations and prevent trading on incomplete information, signalling a potentially significant funding move that could affect existing shareholders and the company’s future development activities.
The most recent analyst rating on (AU:IVX) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Invion stock, see the AU:IVX Stock Forecast page.
More about Invion
Invion Limited (ASX: IVX) is an Australia-based company listed on the Australian Securities Exchange, operating in the life sciences and biotechnology sector with a focus on developing medical technologies and therapies.
Average Trading Volume: 108,755
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$7.79M
For detailed information about IVX stock, go to TipRanks’ Stock Analysis page.